Roman Butler Fullerton & Co’s Colgate-Palmolive CL Stock Holding History

Roman Butler Fullerton & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,430	Closed	-$411K	–	265
2025 Q3	$411K	Buy	+5,430	New	+$463K	0.11%	178
2024 Q4	–	Sell	-4,643	Closed	-$472K	–	238
2024 Q3	$472K	Buy	+4,643	New	+$473K	0.14%	152

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Roman Butler Fullerton & Co's CL Position: Q4 2025 in Review

Roman Butler Fullerton & Co sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 5,430 shares — an estimated $411K sold.

Roman Butler Fullerton & Co first reported a position in CL in Q3 2024 and held it in 2 quarters. The position peaked at $472K in Q3 2024. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

Roman Butler Fullerton & Co reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
Roman Butler Fullerton & Co sold 5,430 Colgate-Palmolive shares in Q4 2025, an estimated $411K.
Roman Butler Fullerton & Co first reported a position in Colgate-Palmolive in Q3 2024 and held it in 2 quarters.
Roman Butler Fullerton & Co's Colgate-Palmolive position peaked at $472K in Q3 2024.
1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Roman Butler Fullerton & Co's 13F filing for Q4 2025, filed 26 Jan 2026.